2014-09-03 21:32:53 UTC

Gastroenterology Podcast September 2014: Vedolizumab for Crohn’s Patients After TNF Therapy Has Failed

A study in the September issue of Gastroenterology evaluated the effects of vedolizumab induction therapy for patients with Crohn’s disease for whom tumor necrosis factor (TNF) antagonists have already failed. Dr. Kuemmerle speaks with the first author of the study, Dr. Bruce E. Sands of the Ichan School of Medicine at Mount Sinai, New York; Plus, a rundown of top stories from this month's issue of GI and Hepatology News.

 

 

Sands BE, Feagan BG, Rutgeerts P, et al. Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed. Gastroenterology 2014; September; 147(3): 618–627.e3
Abstract

 

 

Duration: 16.54m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ

More on Crohn's Disease

Crohn's & Colitis Congress™

Jan. 18, 2018

The Crohn's & Colitis Foundation and AGA are partnering on a new annual conference for health-care professionals and researchers. By joining the nation's leading IBD patient organization with the premier gastroenterological professional organization, this will be the must-attend IBD conference, bringing state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.

Principles of Gastroenterology for the NP and PA

Aug. 11, 2017

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

AGA Plans Education About IBD & Pregnancy

May 18, 2017

UCB provides support, research and education of health-care professionals and patients surrounding the issue.